John Puisis

City:

Northbrook, Illinois

Country:

United States

Published Applications:

Last publication date:

2026-05-28

Top Assignees for applications by John Puisis

The entities that hold a legal rights for patent applications filed by inventor Puisis John:

onCOUR Pharma, Inc. 2 Northbrook, IL United States
Regents of the University of Michigan 1 Ann Arbor, MI United States
COUR PHARMACEUTICALS DEVELOPMENT COMPANY INC. 1 Evanston, IL United States
THE REGENTS OF THE UNIVERSITY OF MICHIGAN 1 Ann Arbor, MI United States
COUR PHARMACEUTICALS DEVELOPMENT COMPANY, INC. 1 Northbrook, IL United States

Recent patent applications by Puisis John

John Puisis from Northbrook, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28

US20260144891A1

Human necessities

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

#2 | 2025-12-04

US20250367274A1

Human necessities

Tolerizing Immune Modifying Nanoparticles for Overcoming the Immunogenicity of Therapeutic Vectors and Proteins

#3 | 2025-05-29

US20250170066A1

Human necessities

TREATMENT OF SOLID TUMORS WITH NEGATIVELY CHARGED PARTICLES

#4 | 2024-06-20

US20240197866A1

Human necessities

TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES

#5 | 2023-10-26

US20230338576A1

Human necessities

COVALENT POLYMER-ANTIGEN CONJUGATED PARTICLES

#6 | 2023-06-22

US20230190895A1

Human necessities

NEGATIVELY CHARGED PARTICLES FOR THE TREATMENT OF CYTOKINE STORM SYNDROME (CSS) AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

#7 | 2022-08-18

US20220257768A1

Human necessities

TREATMENT OF IMMUNE EVASIVE TUMORS

#8 | 2021-09-23

US20210290661A1

Human necessities

IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER

#9 | 2019-09-19

US20190282707A1

Human necessities

Covalent polymer-antigen conjugated particles

#10 | 2019-02-28

US20190060354A1

Human necessities

Immune-modifying nanoparticles for the treatment of inflammatory diseases

InventorID:

2990450 ⎘